Navigation Links
Low-Dose Hormones Help the Bones

Osteoporosis is a major cause of disability in older women. Estrogen therapy is often prescribed to prevent osteoporosis. However, many women are reluctant// to take hormone therapy because of the increased risk of breast cancer, heart disease, stroke and deep vein blood clots. Now, new research finds a lower dosage of estrogen increases bone density in women without possibly causing the problems typically associated with the standard dose of estrogen therapy.

For the study, researchers from the University of Connecticut investigated the effects of one quarter of the dose of estrogen typically prescribed for conventional hormone therapy. Researchers included 167 women older than 65 in the study. The women were randomly assigned to receive the smaller amount of estrogen or placebo. Researchers measured the bone mineral density of the hip, spine, wrist and the total body every year for three years. They also looked at markers for bone resorption and bone formation during the study.

Researchers found women who were on the low dose of estrogen had an increase in their bone mineral density at all the sites measured compared to women on the placebo. They found the markers for bone loss were also significantly decreased in women taking the low-dose estrogen compared to the placebo group. Furthermore, researchers report the number of adverse effects was similar in both groups.

Study authors conclude these results show a low dose of estrogen is effective at preventing bone loss. They hypothesize that lowering the dose of estrogen may also reduce the number of adverse events.
'"/>




Page: 1

Related medicine news :

1. Low-Dose Oral Contraceptives May Increase Risk For Heart Attack Or Stroke
2. FDA To Reconsider Standards for Reviewing Low-Dose Oral Contraceptives
3. Low-Dose Steroids Reduce Joint Damage From Rheumatoid Arthritis
4. Hormones Linked To Migraines
5. Hormones do not guard against heart failure
6. Hormones A Predictor Of Heart Problems
7. Link Between Sex Hormones And Risk Of Breast Cancer
8. Debating The Link Between Sex Hormones And Multiple Sclerosis
9. Teenagers Using Hormones And Dietary Supplements To Good Physique
10. Researchers Purify Protein That Could Regulate Male Hormones
11. Hunger Hormones And Postoperative Obesity Surgery
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2016)... ... ... Spine Team Texas, a comprehensive spine physician group specializing in the treatment ... been invited to be a featured speaker at the Texas Society of the American ... 2016. , Dr. R. Scott McPherson, a physical medicine and rehabilitation specialist, will ...
(Date:4/29/2016)... ... ... Mobility Designed is redefining mobility with their patent pending crutch design. ... distributes body weight from the elbow to the forearm. In consumer tests, users ... other crutches. , Co-founders Max and Liliana Younger were inspired to design the crutches ...
(Date:4/29/2016)... ... April 29, 2016 , ... The Gluten-Free ... is pleased to announce the launch of the GFCP Scoop in ... more. The purpose of the GFCP Scoop site is to keep ...
(Date:4/29/2016)... ... ... Dr. Robert Mondavi, one of the dentists in Torrance , is now ... as more patients are discovering the many different ways they can change and improve ... to them and which ones might work for their smiles. , “One of ...
(Date:4/29/2016)... ... April 29, 2016 , ... Reltok Nasal Products proudly announces ... the head and neck/ear, nose and throat specialty, has added the KOTLER NASAL AIRWAY™ ... NASAL AIRWAY™ is a newly patented safety device secured by nasal surgeons onto ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... 28, 2016  ValGenesis, Inc., the market ... (VLMS) today announced that a prominent world ... of chronic kidney failure has selected ValGenesis ... corporate validation process. The global medical device ... to manage their validation processes electronically. Upon ...
(Date:4/27/2016)... -- Hologic, Inc. (Nasdaq: HOLX ) announced ... second quarter ended March 26, 2016.  GAAP diluted ... and non-GAAP diluted EPS of $0.47 increased 14.6%.  ... reported basis, and 6.3% on a constant currency ... quarter, highlighted by 14.6% growth in non-GAAP EPS," ...
(Date:4/27/2016)... 2016   , ... Recurring Consumable Sales  Clinical sales grow 16% ... (Euronext: MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary ... the first quarter ended March 31, 2016 and provided ... its commercial strategy. First Quarter 2016 Revenue ...
Breaking Medicine Technology: